Skip to main content
SpringerLink
Log in

Therapie der opioidinduzierten Obstipation

Therapy of opioid-induced constipation

  • Literatur im Fokus
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Thomas J (2008) Opioid-induced bowel dysfunction. J Pain Symptom Manage 35: 103–113

    Article  PubMed  CAS  Google Scholar 

  2. Reintam A, Parm P, Redlich U, Tooding et al. (2006) Gastrointestinal failure in intensive care: a retrospective clinical study in three different intensive care units in Germany and Estonia. BMC Gastroenterol 6: 19

    Article  PubMed  Google Scholar 

  3. Mostafa SM, Bhandari S, Ritchie G et al. (2003) Constipation and its implications in the critically ill patient. Br J Anaesth 91: 815–819

    Article  PubMed  CAS  Google Scholar 

  4. Berde C, Nurko S (2008) Opioid side effects – mechanism-based therapy. N Engl J Med 358: 2400–2402

    Article  PubMed  CAS  Google Scholar 

  5. Thomas J, Karver S, Cooney GA et al. (2008) Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358: 2332–2343

    Article  PubMed  CAS  Google Scholar 

  6. Yuan CS, Foss JF (2000) Oral methylnaltrexone for opioid-induced constipation. JAMA 284: 1383–1384

    Article  PubMed  CAS  Google Scholar 

  7. Yuan CS, Doshan H, Charney MR et al. (2005) Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol 45: 538–546

    Article  PubMed  CAS  Google Scholar 

  8. Liu M, Wittbrodt E (2002) Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 23: 48–53

    Article  PubMed  Google Scholar 

  9. Reichle FM, Conzen PF (2008) Methylnaltrexone, a new peripheral mu-receptor antagonist for the prevention and treatment of opioid-induced extracerebral side effects. Curr Opin Investig Drugs 9: 90–100

    PubMed  CAS  Google Scholar 

  10. Liu SS, Hodgson PS, Carpenter RL, Fricke JR Jr (2001) ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin Pharmacol Ther 69: 66–71

    Article  PubMed  CAS  Google Scholar 

  11. Spoel JI van der, Schultz MJ, Voort PH van der, Jonge E de (2006) Influence of severity of illness, medication and selective decontamination on defecation. Intensive Care Med 32: 875–880

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Anaesthesiologie, Ludwig-Maximilians-Universität, Nussbaumstr. 20, 80336, München, Deutschland

    D. Chappell & P. Conzen

Authors
  1. D. Chappell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Conzen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Chappell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chappell, D., Conzen, P. Therapie der opioidinduzierten Obstipation. Anaesthesist 57, 1011–1014 (2008). https://doi.org/10.1007/s00101-008-1420-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-008-1420-0

Search

Navigation